"Phase III clinical trials are not a sports competition," said Yin Weidong, chairman and CEO of Chinese vaccine developer Sinovac as he revealed the scale and complexity of trials his company has conducted in an attempt to provide an antidote to the ravaging coronavirus pandemic.
[ Ссылка ]
Welcome to subscribe us on:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Video on Demand: www.cctvplus.com
If you are in demand of this video footage, please contact with our business development team via email: service@cctvplus.com
